Can medical cannabis relieve chemotherapy-induced neuropathic pain?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Yes, research and patient reports suggest that cannabis for chemotherapy-induced neuropathic pain may offer meaningful relief. Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatments that causes burning, tingling, and numbness in the hands and feet. It can severely affect quality of life and may persist even after treatment ends.

As conventional medications often fall short, cannabis for chemotherapy-induced neuropathic pain has become a growing area of interest, particularly in supportive oncology care.

How Cannabis Helps with Chemo-Induced Neuropathy

Medical cannabis interacts with the endocannabinoid system, which plays a role in pain regulation and nerve function. Here’s how it may support patients experiencing neuropathy from chemotherapy.

Pain relief and nerve signal modulation

Cannabinoids like THC and CBD may reduce the intensity of nerve pain by altering how pain signals are processed in the brain and peripheral nervous system. This supports the use of cannabis for chemotherapy nerve pain in managing both acute and chronic symptoms.

Anti-inflammatory properties

Cannabis may reduce inflammation around damaged nerves, easing pressure and sensitivity that worsen neuropathic pain.

Improved sleep and anxiety management

Cancer patients often experience anxiety and sleep disturbances linked to pain. Medical cannabis for chemo neuropathy can offer a dual benefit by promoting rest and reducing stress.

Potential neuroprotective effects

Early research suggests cannabis may help protect nerve cells from further damage, though more evidence is needed to confirm this role in cannabis for chemotherapy pain relief.

In summary, cannabis for chemotherapy-induced neuropathic pain presents a promising option for patients who haven’t found success with standard medications. However, it should always be used under the guidance of a healthcare provider familiar with oncology and cannabinoid therapies.

If you’re exploring cannabis treatment options for neuropathic pain, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and neuropathic pain

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.